Using the Ultima Genomics’ (CA, USA) lower-cost WGS platform and the known mutational patterns in patient tumors as a guide, ...

Grail’s cutting-edge cancer blood test has stirred investor excitement many times in the past few years. With the stock down 55% from its February peak, Canaccord Genuity issued a Buy recommendation ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

In a promising advancement for cancer care, doctors at AIIMS Delhi have developed a new blood test that could assist in keeping track of whether a cervical treatment is working or if the disease ...

A simple blood test may help determine whether your cervical cancer is responding to treatment or whether it has relapsed, shows early research by doctors from the All India Institute of Medical ...

“Structural variants like gene fusions are central to cancer diagnostics, but current clinical tests miss many events that are crucial to diagnostic and therapeutic decision-making,” said Matija ...

A novel blood test that detects a key biomarker for Alzheimer’s disease (AD) could help physicians more accurately determine the presence and track disease progression. The test measures levels ...

Photo by Yulia Karra The vision of the final product is a home blood test that could be purchased at a pharmacy, like Covid or pregnancy tests. Abnormal results would not necessarily indicate cancer ...

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis of Alzheimer's disease. The immunoassay measures the ratio of ptau-217 and beta amyloid 42, two distinct ...

After the three-year project, it’s hoped that the condition could be diagnosed through a simple blood test. Dr Gael Morrow, who is leading the research, told STV News: “Any understanding in the ...

Physiologically, it occurs when blood vessels just below the surface of the ... American Cancer Society. Tests for gastrointestinal carcinoid tumors. Ravikumar R, Avasthi S, Avasthi D. Flushing: A ...

Clinical Director of the Gastrointestinal Cancer Center and Director of the Program in Carcinoid and Neuroendocrine Tumors at Dana-Farber Cancer Institute. "It was encouraging to see that ...